7 Analysts Have This to Say About Cabaletta Bio
Portfolio Pulse from Benzinga Insights
Over the last quarter, Cabaletta Bio (NASDAQ:CABA) has received 7 bullish analyst ratings, with an average 12-month price target of $28.57, a significant increase from the previous average of $14.50. No bearish or indifferent ratings were observed.
October 24, 2023 | 12:00 pm
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
Cabaletta Bio has received positive analyst ratings, which could potentially boost its stock price in the short term.
Analyst ratings often influence investor sentiment and can impact a company's stock price. In this case, Cabaletta Bio has received 7 bullish ratings, which indicates a positive outlook for the company's stock. This could potentially lead to an increase in its stock price in the short term.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100